Patents by Inventor Padraig Moran

Padraig Moran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of inotuzumab ozogamicin and torisel for the treatment of cancer
    Patent number: 9642918
    Abstract: The present invention relates to a therapeutic method for the treatment of cancer that comprises the use of a combination of inotuzumab ozogamicin (CMC-544) and temsirolimus. The enhanced antitumor of the combination therapy is particularly useful for patient population that are recalcitrant to inotuzumab ozogamicin or temsirolimus therapy, relapse after treatment with inotuzumab ozogamicin or temsirolimus or where enhanced antitumor effect reduces toxicities associated with treatment using inotuzumab ozogamicin or temsirolimus.
    Type: Grant
    Filed: December 4, 2012
    Date of Patent: May 9, 2017
    Assignees: Pfizer Inc., Oncology Institute of Southern Switzerland
    Inventors: Andreas Bruederle, Padraig Moran, Anastasios Stathis
  • COMBINATION OF INOTUZUMAB OZOGAMICIN AND TORISEL FOR THE TREATMENT OF CANCER
    Publication number: 20140335109
    Abstract: The present invention relates to a therapeutic method for the treatment of cancer that comprises the use of a combination of inotuzumab ozogamicin (CMC-544) and temsirolimus. The enhanced antitumor of the combination therapy is particularly useful for patient population that are recalcitrant to inotuzumab ozogamicin or temsirolimus therapy, relapse after treatment with inotuzumab ozogamicin or temsirolimus or where enhanced antitumor effect reduces toxicities associated with treatment using inotuzumab ozogamicin or temsirolimus.
    Type: Application
    Filed: December 4, 2012
    Publication date: November 13, 2014
    Applicant: ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND
    Inventors: Andreas Bruederle, Padraig Moran, Anastasios Stathis
  • Device to facilitate the deployment of mobile virtual private networks for medium/large corporate networks
    Publication number: 20070008924
    Abstract: A mobile agent device in a Mobile Virtual Private Network, said device comprising: termination of Mobile IP tunnel (6) from a remotely connecting Mobile Node (1); termination of an IPSec VPN tunnel (7) from the remotely connecting Mobile Node; dynamic Selection of Internal Mobile IP Home Agent based on user Authentication; tunneling of traffic to and/or from the assigned Internal Mobile Home Agent for this Mobile Node; and, provision of extended authentication, after Mobile IP connection establishment, and during the VPN negotiation phase, based on extra user credentials, one-time-password mechanism or similar.
    Type: Application
    Filed: January 17, 2005
    Publication date: January 11, 2007
    Inventor: Padraig Moran